Astec Lifesciences has informed that as per the Company’s Code of Conduct for Prohibition of Insider Trading, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the securities of the Company will be closed with effect from 1st April, 2018 till 48 hours after the declaration of the Audited Financial Results of the Company for the Quarter and Financial Year ending 31st March, 2018. Accordingly all Officers and Designated Employees (including Directors and Auditors) of the Company have been intimated not to trade in (buy or sell) Equity Shares of the Company during the stated period.
The above information is a part of company’s filings submitted to BSE.
